LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration

Author(s):  Shields David E, Aclan Jennifer, Szatkowski Aaron

Issue:  Sep/Oct 2008 - Veterinary Compounding
View All Articles in Issue

Abstract:  Although the U.S. Food and Drug Administration has not approved the combined use of intrathecal medications, practitioners frequently prescribe combination intrathecal therapy for patients who do not experience adequate analgesia with a single intrathecal agent; however, the chemical stability of an analgesic combination may influence the frequency of pump refills necessary to maintain safe and effective pain control. This investigation was performed to evaluate the chemical stability of admixtures containing 25 mcg/mL ziconotide and either 1000 mcg/mL fentanyl citrate or 1000 mcg/mL sufentanil citrate during simulated intrathecal infusion under laboratory conditions at 37°C. Admixtures were prepared from commercial ziconotide (25 mcg/mL) and lyophilized powders of the opioid drugs, sparged with nitrogen to remove dissolved oxygen, and stored in implantable intrathecal pumps at 37°C. Samples obtained at various intervals over the course of 40 days were assessed for drug concentrations by using high-performanc

Related Keywords: David E. Shields, PhD, Jennifer Aclan, BSc, Aaron Szatkowski, BSc, ziconotide, fentanyl, sufentanil, nonopioid analgesics, opioid analgesics, pain relief, analgesia, intrathecal administration, intraspinal administration, spinal administration, drug admixtures, combination therapy, stability, compatibility

Related Categories: PAIN MANAGEMENT, PARENTERALS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration Shields David E, Aclan Jennifer, Szatkowski Aaron Sep/Oct 2008 463-466 Buy
Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration Shields David E, Aclan Jennifer, Szatkowski Aaron Nov/Dec 2008 553-557 Buy
Dilution and Compounding of Ziconotide for Intrathecal Administration Buchta Tony, Fakata Keri, Stuart William May/Jun 2008 200-207 Buy
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III May/Jun 2010 182-192 Buy
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents Logomasini Mark A, Stout Richard R, Ron Marcinkoski Jul/Aug 2013 270-280 Buy
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets Rice Stephen P Mar/Apr 2002 120-122 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Miller David G May/Jun 2014 208 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample